Security key
10501E201
BRAINSTORM CELL THERAPEUTICS - COM NEW (BCLI)
CUSIP: 10501E201
Q1 2020 13F Holders as of 31 Mar 2020
- Security type / class
- Equity / COM NEW
- Total 13F shares
- 3,694,659
- Total 13F value
- $17,120,545
- Share change
- +1,621,571
- Put/Call ratio
- 47%
- SEC-reported price per share
- $4.64
- Number of holders
- 49
- Value change
- +$7,570,023
- Number of buys
- 34
- Number of sells
- 7
Open additional details 1 more signal available
Report period
Q1 2020
Institutions
49
Top holders
10
BCLI full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2020
Previous quarter: Q4 2019
BRAINSTORM CELL THERAPEUTICS INC. SEC filings
BRAINSTORM CELL THERAPEUTICS INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 10501E201
Recent filing periods:
Ownership snapshot
Top reported holders of BCLI - BRAINSTORM CELL THERAPEUTICS - COM NEW (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
0/15
Latest evidence
31 Dec 2019
13F
Highest disclosed value: $3,304,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC has the largest disclosed position value at $3.3M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Disclosed position value
Top 5
VANGUARD GROUP INC
$3.3M
RENAISSANCE TECHNOLOGIES LLC
$1.43M
BlackRock Finance, Inc.
$709K
GEODE CAPITAL MANAGEMENT, LLC
$613K
RAYMOND JAMES & ASSOCIATES
$520K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
Company
|
—
class O/S missing
|
$3,304,000
772,068 shares
|
— | 31 Dec 2019 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
—
class O/S missing
|
$1,429,000
333,932 shares
|
— | 31 Dec 2019 |
| BlackRock Finance, Inc. |
13F
Company
|
—
class O/S missing
|
$709,000
165,539 shares
|
— | 31 Dec 2019 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
class O/S missing
|
$613,000
143,236 shares
|
— | 31 Dec 2019 |
| RAYMOND JAMES & ASSOCIATES |
13F
Company
|
—
class O/S missing
|
$520,000
121,600 shares
|
— | 31 Dec 2019 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
—
class O/S missing
|
$280,000
65,306 shares
|
— | 31 Dec 2019 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
49
Shares
3,694,659
Rows available
49
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2020 vs Q4 2019 Across Filers
Q4 2019 holders
41
Q1 2020 holders
49
Holder diff
8
| Investor | Q4 2019 Shares | Q1 2020 Shares | Share Diff | Share Chg % | Q4 2019 value | Q1 2020 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend